erdafitinibe - uma nova opção para o carcinoma urotelial metastático
Published 5 years ago • 483 plays • Length 4:20Download video MP4
Download video MP3
Similar videos
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
40:58
urothelial carcinoma: advances in immuno-oncology
-
2:12
erdafitinib: one more tool for bladder cancer
-
1:28
erdafitinib for bladder cancer: more to come following fda approval
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
9:43
erdafitinib for urothelial carcinoma, ttfields in nsclc, ai-powered device to detect skin...
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
36:28
advances in immuno-oncology in urothelial carcinoma
-
4:43
erdafitinib for fgfr-mutated urothelial carcinoma
-
24:14
chemo-ablation of upper-tract urothelial carcinoma
-
13:47
ev-103: enfortumab vedotin and pembrolizumab in urothelial carcinoma
-
1:24
ev-103 cohort h: neoadjuvant enfortumab vedotin monotherapy in cisplatin-ineligible mibc
-
1:18
dr. hoffman-censits on biomarker development in urothelial carcinoma
-
0:49
dr. daniele on impact of regorafenib in hcc
-
1:15
dll3, a new biomarker for neuroendocrine tumors of the lung
-
8:06
adaura: osimertinib post-tumor resection in nsclc
-
2:04
unmet need in bladder cancer